A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS

Clinical trial NCT04477291 · TERMINATED

Trial details

NCT number: NCT04477291
Sponsor: Aptose Biosciences Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndromes

Start date: 2020-10-06
Primary completion: 2024-04-15
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.